Residual Pulmonary Hypertension Clinical Trial
Official title:
Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension
To assess the effectiveness of the synthetic analogue of prostacyclin in postembolic residual pulmonary hypertension.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment